IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

ABG Innovation Capital Partners III GP Ltd

Q2 2021 Holdings

Filed 2021-08-16 | 7 holdings | $27.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Atea Pharmaceuticals Inc(AVIR)COM04683R106$27.2M1,265,631100.0%
Genocea Biosciences Inc(GNCAQ)COM NEW372427401$878375,0000.0%
Synlogic IncCOM87166L100$801205,9060.0%
Aerpio Pharmaceuticals IncCOM00810B105$676400,0000.0%
Pulmonx Corp(LUNG)COM745848101$1994,5210.0%
Idera Pharmaceuticals IncCOM PAR45168K405$6856,2500.0%
Nabriva Therapeutics PLCSHSG63637113$6245,8490.0%